SRZN Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration...

Stats
Dagens volum	11 124.00
Gjennomsnittsvolum	16 966.00
Markedsverdi	28.72M
EPS	$0 ( 2024-04-03 )
Neste inntjeningsdato	( $-4.25 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.420
ATR14	$0.150 (1.67%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Li Yang	Buy	10 000	Option (right to buy)
2024-04-24	Li Yang	Buy	5 000	Restricted Stock Unit
2024-04-24	Parker Craig C	Buy	43 000	Option (right to buy)
2024-04-24	Williams Charles O	Buy	13 000	Option (right to buy)
2024-04-24	Williams Charles O	Buy	7 000	Restricted Stock Unit

INSIDER POWER
92.41
Last 99 transactions
Buy: 7 137 981 \| Sell: 808 309

Surrozen, Inc. Korrelasjon

10 Mest positive korrelasjoner
NXTC	0.94
PVBC	0.939
TOI	0.936
HHGCU	0.933
STSA	0.916
JNCE	0.916
PRVA	0.915
FAAR	0.909
VSTA	0.903
LPTX	0.9

10 Mest negative korrelasjoner
NRIM	-0.942
AMRB	-0.937
MDLZ	-0.928
CLRO	-0.928
LYLT	-0.923
STIM	-0.917
PBFS	-0.904
PRDO	-0.903
VLYPO	-0.901
LVHD	-0.901

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Surrozen, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-1.91M (0.00 %)
EPS:	$-21.33

FY	2023
Omsetning:	$0
Bruttogevinst:	$-1.91M (0.00 %)
EPS:	$-21.33

FY	2022
Omsetning:	$12.50M
Bruttogevinst:	$9.23M (73.85 %)
EPS:	$-11.95

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.556

Financial Reports:

No articles found.

Surrozen, Inc.

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.